The Effects of Allopurinol in Chronic Kidney Disease Patients
Phase 4
Completed
- Conditions
- Chronic Kidney DiseaseRenal and Urogenital - Kidney disease
- Registration Number
- ACTRN12614000320651
- Lead Sponsor
- Dilara Bayram
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
The inclusion criteria were as follows; being a CKD patient at stage 2-4, age between 18 and 80 years old, having serum uric acid levels over 5.5 mg/dl and giving written informed consent to enter this study.
Exclusion Criteria
The exclusion criteria were: being on renal replacement therapy, hyperuricemia due to malignancy, having peripheral arterial disease, gouty arthritis, a history of allopurinol intolerance, being already on allopurinol treatment, having active infections or inflammatory diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method differences in creatinine clearance. Creatinine clearances of the patients were assessed via 24 hour urine collection[assessed at three months from baseline]
- Secondary Outcome Measures
Name Time Method